Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 4
1986 1
1987 4
1988 7
1989 2
1990 9
1991 6
1992 11
1993 7
1994 7
1995 5
1996 6
1997 3
1998 5
1999 9
2000 3
2001 10
2002 12
2003 7
2004 22
2005 16
2006 22
2007 25
2008 32
2009 40
2010 50
2011 53
2012 34
2013 51
2014 47
2015 40
2016 49
2017 41
2018 43
2019 51
2020 65
2021 70
2022 66
2023 61
2024 44
2025 37

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

917 results

Results by year

Filters applied: . Clear all
Page 1
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Ellen Csuka M, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE. van den Hoogen F, et al. Among authors: matucci cerinic m. Ann Rheum Dis. 2013 Nov;72(11):1747-55. doi: 10.1136/annrheumdis-2013-204424. Ann Rheum Dis. 2013. PMID: 24092682 Free article.
An international perspective on the future of systemic sclerosis research.
Abraham DJ, Black CM, Denton CP, Distler JHW, Domsic R, Feghali-Bostwick C, Gourh P, Hinchcliff M, Kolling F 4th, Kuwana M, Lafyatis R, Landegren U, Mahoney JM, Martin J, Matucci-Cerinic M, McMahan ZH, Mora AL, Mouthon L, Rabinovitch M, Rojas M, Rubin K, Trojanowska M, Varga J, Whitfield ML, Gabrielli A, Krieg T. Abraham DJ, et al. Among authors: matucci cerinic m. Nat Rev Rheumatol. 2025 Mar;21(3):174-187. doi: 10.1038/s41584-024-01217-2. Epub 2025 Feb 14. Nat Rev Rheumatol. 2025. PMID: 39953141 Review.
Connective tissue diseases.
Furst DE, Matucci Cerinic M. Furst DE, et al. Among authors: matucci cerinic m. Best Pract Res Clin Rheumatol. 2007 Dec;21(6):969-70. doi: 10.1016/j.berh.2007.11.001. Best Pract Res Clin Rheumatol. 2007. PMID: 18068855 No abstract available.
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.
Spiera R, Kuwana M, Khanna D, Hummers L, Frech TM, Stevens W, Matucci-Cerinic M, Kafaja S, Distler O, Jun JB, Levy Y, Leszcyzński P, Gordon J, Steen V, Lee EB, Jankowski T, Litinsky I, Chung L, Hsu V, Mayes M, Sandorfi N, Simms RW, Finzel S, de Vries-Bouwstra J, Constantine S, Dgetluck N, Dinh Q, Bloom BJ, Furst DE, White B, Denton CP; RESOLVE-1 Study Group. Spiera R, et al. Among authors: matucci cerinic m. Arthritis Rheumatol. 2023 Sep;75(9):1608-1618. doi: 10.1002/art.42510. Epub 2023 Jun 15. Arthritis Rheumatol. 2023. PMID: 37098795 Free article. Clinical Trial.
Very early systemic sclerosis.
Bellando-Randone S, Matucci-Cerinic M. Bellando-Randone S, et al. Among authors: matucci cerinic m. Best Pract Res Clin Rheumatol. 2019 Aug;33(4):101428. doi: 10.1016/j.berh.2019.101428. Epub 2019 Sep 3. Best Pract Res Clin Rheumatol. 2019. PMID: 31810547 Review.
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial.
Distler O, Allanore Y, Denton CP, Kuwana M, Matucci-Cerinic M, Pope JE, Atsumi T, Bečvář R, Czirják L, Hachulla E, Ishii T, Ishikawa O, Johnson SR, De Langhe E, Stagnaro C, Riccieri V, Schiopu E, Silver RM, Smith V, Steen V, Stevens W, Szücs G, Truchetet ME, Wosnitza M, Laapas K, Kramer F, Khanna D. Distler O, et al. Among authors: matucci cerinic m. Lancet Rheumatol. 2023 Nov;5(11):e660-e669. doi: 10.1016/S2665-9913(23)00238-2. Lancet Rheumatol. 2023. PMID: 38251533 Clinical Trial.
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).
Bellando-Randone S, Del Galdo F, Lepri G, Minier T, Huscher D, Furst DE, Allanore Y, Distler O, Czirják L, Bruni C, Guiducci S, Avouac J, Cutolo M, Smith V, Matucci-Cerinic M; Very Early Diagnosis of Systemic Sclerosis collaborators. Bellando-Randone S, et al. Among authors: matucci cerinic m. Lancet Rheumatol. 2021 Dec;3(12):e834-e843. doi: 10.1016/S2665-9913(21)00244-7. Lancet Rheumatol. 2021. PMID: 38287630
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases.
Coccia C, Bonomi F, Lo Cricchio A, Russo E, Peretti S, Bandini G, Lepri G, Bartoli F, Moggi-Pignone A, Guiducci S, Del Galdo F, Furst DE, Matucci Cerinic M, Bellando-Randone S. Coccia C, et al. Among authors: matucci cerinic m. Biomedicines. 2024 Aug 5;12(8):1760. doi: 10.3390/biomedicines12081760. Biomedicines. 2024. PMID: 39200224 Free PMC article. Review.
Pathophysiology of Hemophilic Arthropathy.
Melchiorre D, Manetti M, Matucci-Cerinic M. Melchiorre D, et al. Among authors: matucci cerinic m. J Clin Med. 2017 Jun 25;6(7):63. doi: 10.3390/jcm6070063. J Clin Med. 2017. PMID: 28672826 Free PMC article. Review.
917 results